X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

HEMATOLOGICAL ONCOLOGY

期刊標題檢索 HEMATOL ONCOL 最新評論: Do I need to pay a review fee? I don't have any money, they didn't ev... (2023-06-05)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[HEMATOLOGICAL ONCOLOGY]您好,您是該頁面的第 26244 位訪客。

期刊簡介
期刊名稱HEMATOLOGICAL ONCOLOGY HEMATOLOGICAL ONCOLOGY
LetPub Score
6.2
50 ratings
Rate

Reputation
7.6

Influence
4.9

Speed
7.0

期刊簡稱HEMATOL ONCOL
ISSN0278-0232
E-ISSN1099-1069
h-index42
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.200.8200.717
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Hematology
Q265 / 137
Category: Medicine
Subcategory: Oncology
Q2197 / 404
Category: Medicine
Subcategory: Cancer Research
Q3146 / 230

自引率 (2023-2024)6.10%自引率趨勢
掲載範囲
Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:

-Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders
-Diagnostic investigations, including imaging and laboratory assays
-Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases
-Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies
-Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.
Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.
官方網站http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1069
在線稿件提交https://mc.manuscriptcentral.com/hon
開放訪問No
出版商John Wiley and Sons Ltd
主題領域医学
出版國/地區ENGLAND
發行頻率四半期刊行
創刊年1983
每年文章數93每年文章數趨勢
黃金OA百分比30.61%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
HEMATOLOGYSCIEQ230/97
ONCOLOGYSCIEQ2118/322
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0278-0232%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【HEMATOLOGICAL ONCOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Hematology & OncologyH-index: 60

    CiteScore: 48.10
    BLOODH-index: 426

    CiteScore: 23.60
    LEUKEMIAH-index: 176

    CiteScore: 18.10
    AMERICAN JOURNAL OF HEMATOLOGYH-index: 92

    CiteScore: 15.70
    HAEMATOLOGICAH-index: 125

    CiteScore: 14.10
    BLOOD REVIEWSH-index: 85

    CiteScore: 13.80
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGYH-index: 111

    CiteScore: 11.00
    BRITISH JOURNAL OF HAEMATOLOGYH-index: 172

    CiteScore: 8.60
    SEMINARS IN HEMATOLOGYH-index: 88

    CiteScore: 6.20
    CURRENT OPINION IN HEMATOLOGYH-index: 90

    CiteScore: 6.60
    學科內最受檢索的期刊 頁面查看次數
    BLOOD111053
    Journal of Hematology & Oncology101264
    LEUKEMIA58203
    BRITISH JOURNAL OF HAEMATOLOGY50936
    LEUKEMIA & LYMPHOMA44526
    Hematology37485
    ANNALS OF HEMATOLOGY36121
    AMERICAN JOURNAL OF HEMATOLOGY35412
    LEUKEMIA RESEARCH34144
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY32877
  •  

    HEMATOLOGICAL ONCOLOGY HEMATOLOGICAL ONCOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [HEMATOLOGICAL ONCOLOGY] 的評論撰寫評論
作者: 雾水立顺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-05 20:09:26 評論於
Do I need to pay a review fee? I don't have any money, they didn't even ask me to pay
(0) 讚! | 雾水立顺

作者: 一吃就胖小怜容


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-13 11:07:37 評論於
The review fee is 70 euros. I spent the whole afternoon trying to pay it, but couldn't. Damn this magazine, I'll have to find another one
(0) 讚! | 一吃就胖小怜容

作者: 努力啊大令枫


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-18 20:55:15 評論於
Have you ever encountered a situation where you are trying to retrieve your password, and the verification code you entered in your email is correct, but it keeps saying the code is incorrect?
(0) 讚! | 努力啊大令枫

作者: Perry Ellen


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-29 21:55:54 評論於
Isn't this published in the UK?
(0) 讚! | Perry Ellen

作者: 气甲强圉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-08 19:05:44 評論於
Is this article specifically about tumors related to blood?
(0) 讚! | 气甲强圉

作者: 气甲强圉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-03-08 12:01:09 評論於
Is this article only about tumors related to blood?
(0) 讚! | 气甲强圉

作者: 星熊雯清


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-24 15:34:25 評論於
Do you need the raw data? Are there any specific formatting requirements?
(0) 讚! | 星熊雯清

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:30:35 評論於
When describing one's innovation, it is important to focus on the deficiencies of past research and provide a complete and clear description of one's proposed solution. The introduction of innovation requires the use of rhetorical techniques, and it is advisable to highlight content that is favorable to oneself. In order to emphasize the novelty of one's research, it is necessary to select citations that highlight the differences and unique aspects of the study. For example, (1) time issues; (2) research methods; (3) study area; (4) uncertainties; (5) proposing hypotheses for verification
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:29:49 評論於
Introduction includes all or some of the following five items: introduction to the background, significance, current status (shortcomings) of the research field, research purposes, and a summary of the content of the research
(0) 讚! | 维尔娜菲茨杰拉德

作者: 破戒阳平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 18:17:52 評論於
How is the innovation of the article reflected in the introduction?
(0) 讚! | 破戒阳平

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 20:54:59 評論於
What should be included in the introduction?
(0) 讚! | 陶宜三岁啦

作者: 东风屠维


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-23 12:09:54 評論於
Although it's tough, I still want to share my experience: I submitted my work from December 12th to 15th, but it was rejected without any reasons on December 23rd. They just said I submitted too much and suggested me to try again. After all, the rejection speed is still okay
(0) 讚! | 东风屠维

作者: 珉林高峰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-15 15:19:36 評論於
Benefit a lot
(0) 讚! | 珉林高峰

作者: 北陆佩玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-08 19:21:12 評論於
Not using OA does not cost money
(0) 讚! | 北陆佩玉

作者: 明冠鹏宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-20 10:56:20 評論於
It's okay if you don't do online advertising, it won't cost you anything. The online advertising has generated over 20,000
(0) 讚! | 明冠鹏宇

作者: 雨晨小姐姐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-18 16:47:35 評論於
How much is the layout fee for this magazine?
(0) 讚! | 雨晨小姐姐

作者: 明冠鹏宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-11 14:22:24 評論於
Does this magazine pay for submissions?
(0) 讚! | 明冠鹏宇

作者: 明冠鹏宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-11 12:23:36 評論於
About a month has passed pretty quickly
(0) 讚! | 明冠鹏宇

作者: 明冠鹏宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-09 18:39:44 評論於
How much is the advertising fee usually?
(0) 讚! | 明冠鹏宇

作者: 明冠鹏宇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-09 17:29:23 評論於
Review Speed: 1.0 | Submission Acceptance Rate: 50.0
Experience Sharing: Submitted on 2020-9-1, Revised on 2020-10-6, Resubmitted on 2020-12-1, Accepted on 2020-12-6
(0) 讚! | 明冠鹏宇

作者: 震雷青燕


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-12-02 16:07:56 評論於
Is the review process fast?
(0) 讚! | 震雷青燕

作者: 春白殿下


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-09-15 21:52:20 評論於
Our research group has already submitted the paper, so there is no need to invite us to contribute
(0) 讚! | 春白殿下

作者: Don Titus


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-12-19 18:08:06 評論於
Is it true that this magazine only accepts commissioned articles?
(0) 讚! | Don Titus

作者: 辉夜碧秋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-11-07 19:05:49 評論於
Is this magazine only accepting commissioned articles?
(0) 讚! | 辉夜碧秋

作者: 燕伟小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-09-07 14:41:02 評論於
What kind of articles are popular for publication?
(0) 讚! | 燕伟小公主

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [HEMATOLOGICAL ONCOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*